期刊文献+

RNAi技术干扰TGF-β/Smads表达对卵巢癌细胞株的影响作用

Effect of RNAi Technique on Ovarian Cancer Cell Lines by Interfering with the Expression of Smads/TGF-β
下载PDF
导出
摘要 目的研究RNAi技术干扰TGF-β/Smads表达对卵巢癌细胞株的影响作用。方法将卵巢细胞SKOV3细胞体外培养,随机分为对照组、空白载体组和siRNA干扰组。采用免疫组化法比较三组的TGFRβⅠ、TGFRβⅡ、Smad2、Smad3、Smad4、Smad7表达水平以及细胞生长速度、凋亡率。结果 siRNA干扰组的TGFRβⅠ、Smad7表达水平显著高于对照组和空白载体组(P<0.05),而TGFRβⅡ、Smad2、Smad3、Smad4表达水平低于对照组和空白载体组(P<0.05)。siRNA干扰组接种24h、48 h和72 h时的吸光度显著低于对照组和空白载体组(P<0.05)。siRNA干扰组的细胞凋亡率显著高于对照组和空白载体组(P<0.05)。结论 RNAi技术可干扰TGF-β/Smads表达,对卵巢癌细胞株的生长具有抑制作用。 Objective To study the effect of RNAi technique on ovarian cancer cell lines by interfering with the expression of TGF-fl/Smads. Methods Ovarian SKOV3 cells were cultured in vitro and randomly divided into control group, empty vector group and siRNA interference group. The expression levels of TGFRβI , TGFRβⅡ Smad2, Smad3, Smad4 and Smad7, and cell growth rate and apoptosis rate were compared among three groups by immunohistochemistry. Results The expression levels of TGFRβI and Smad7 of siRNA interference group were significantly higher than those of control group and empty vector group (P 〈0.05), but the expression levels of TGFRβⅡ, Smad2, Smad3 and Smad4 were lower than those of control group and empty vector group (P〈0.05). The absorbance at 24 h, 48 h and 72 h in siRNA interference group were significantly lower than those in control group and empty vector group (P 〈0.05). The apoptosis rate of siRNA interference group was significantly higher than those of control group and empty vector group (P 〈0.05). Conclusions RNAi technique can interfere with the expression of TGF-β/Smads, so as to inhibit the growth of ovarian cancer cell lines.
出处 《临床医学工程》 2017年第3期330-331,共2页 Clinical Medicine & Engineering
基金 珠海市医疗卫生科技计划项目(编号:20161027E030061)
关键词 RNAI 卵巢癌 TGF-Β SMADS RNAi Ovarian cancer TGF-β Smads
  • 相关文献

参考文献2

二级参考文献23

  • 1Dowdy S C, Mariani A, Reirlholz M M, et al. Overexpression of the TGF-beta antagonist Smad7 in endometrial cancer[J]. Gynecol Oncol, 2005, 96(2) :368-373.
  • 2Luo X, Xu J, Chegini N. Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells [J]. Reprod Biol Endocrinol, 2003, 1 ( 1 ) : 125.
  • 3Lessey B A, llesanmi A O, Castelbaum A J, et al. Characterization of the functional progesterone receptor in an endometrial adenocarcinoma cell line (Ishikawa) : progesterone-induced expression of the alphal integrin [ J ]. Y Steroid Biochem Mol Biol, 1996, 59(1) :31-39.
  • 4Inman G J, Allday M J. Resistance to TGF-betal correlates with a reduction of TGF-beta type Ⅱ receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines [J]. J Gen Virol,2000,81(6) :1567-1578.
  • 5Li H, Fan X, Houghton J. Tumor microenvironment: the role of the tumor stroma in cancer [J]. J Cell Biochem, 2007, 101 (4) :805-815.
  • 6Piestrzeniewicz-Ulanska D, Brys M, Semczuk A, et ah Expression of TGF-beta type Ⅰ and Ⅱ receptors in normal and cancerous human endometrium [J]. Cancer Lett, 2002, 186 (2) :231-239.
  • 7Kretschmer A, Moepert K, Dames S, et al. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4 [J]. Oncogene, 2003, 22(43):6748-6763.
  • 8Moren A, Hellman U, Inada Y. Differential ubiquitination defines the functional status of the tumor suppressor Smad4 [J]. J Biol Chem, 2003, 278(35):33571-33582.
  • 9Luo X, Xu J, Chegini N. The expression of smads in human endometrial and regulation and induction in endometrial epithelial and stromal cells by transforming growth factor-beta [J]. J Clin Endocrinol Metab, 2003, 88(10):4967-4976.
  • 10de Wever O, Mareel M. Role of tissue stroma in cancer cell invasion [J]. J Pathol, 2003, 200(4):429-447.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部